Send the following on WhatsApp
Continue to Chat中國 PAT 兌現承諾!支付 CASI anti-CD38 單株抗體款項以獲研發資格! https://geneonline.news/pat-casi-anti-cd38/?variant=zh-cn
中國 PAT 兌現承諾!支付 CASI anti-CD38 單株抗體款項以獲研發資格! https://geneonline.news/pat-casi-anti-cd38/?variant=zh-cn